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phenotypes than the ones observed. 
V0a1 subunits are implicated in vesicle 
fusion independent of their role in acidifi-
cation (Marshansky and Futai, 2008), and 
it might be interesting to study that aspect 
in more depth. Finally, full-length preseni-
lin 1, present in low amounts in the endo-
plasmic reticulum, is proposed to act as a 
Ca2+-leak channel (Tu et al., 2006), and it 
is unclear how the new proposed function 
relates to this previous one.
The new work underscores the impor-
tance of presenilin 1 function in the endo-
plasmic reticulum and confirms its role 
in subcellular trafficking, in particular in 
the autophagocytic/lysosomal pathways. 
Taking these intriguing observations as a 
starting point, further in-depth exploration 
of the precise mechanism will ultimately 
result in a better understanding of the myr-
iad functions of presenilins in health and 
disease.
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A revolution is occurring in our under-
standing of the genetic basis of common 
chronic diseases such as arthritis, Crohn’s 
disease, and cancer. Genome-wide asso-
ciation studies (GWAS) are identifying a 
plethora of common sequence variants of 
genes and of putative regulatory regions 
in or near genes that predispose an indi-
vidual to developing a particular disease. 
This flood of new information is made 
possible by dramatic improvements in 
the genotyping of DNA polymorphisms 
across the human genome, increased 
levels of statistical rigor during the inter-
pretation of results, and the large-scale 
collection of clinical resources. Never-
theless, doubts concerning the value 
of GWAS have arisen because in many 
cases a particular polymorphism only 
slightly increases an individual’s risk for 
developing that disorder. Hence, some 
researchers ask, how can such a small 
genetic effect provide useful insights into 
the mechanisms of the disease? How-
ever, more pertinent questions are, which 
particular genes mapped by GWAS are 
involved in the etiology or cause of the 
disease and how do these genes act?
One common disorder for which GWAS 
have been spectacularly successful is a 
severe form of gut inflammation called 
Crohn’s disease. GWAS of Crohn’s dis-
ease patients provided the first clues that 
alterations in the expression and activities 
of genes known to function in autophagy 
(i.e., the pathway that degrades intracel-
lular components, including pathogens) 
may predispose individuals to inflamma-
tion of the small intestine (Wellcome Trust 
Case Control Consortium, 2007). Two ear-
lier studies, one by Cadwell et al. (2008) 
and another by Saitoh et al. (2008), took 
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Information obtained from genome-wide association studies has cracked open the biology of 
common chronic diseases by identifying genes that predispose individuals to these disorders. 
Cadwell et al. (2010) now demonstrate that a viral infection, a toxic insult to the gut, commensal 
bacteria, and a Crohn’s disease susceptibility gene collude to cause inflammatory disease in the 
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the next steps after the GWAS 
investigations by modeling in 
mice the effects of the Crohn’s 
disease gene ATG16L1. This 
gene was already associated 
with autophagy, and in both 
studies, mice engineered with 
deficiencies in the Atg16L1 
gene displayed gut inflamma-
tory phenotypes not previously 
associated with autophagy. 
Reducing the function of 
Atg16L1 in mice caused sig-
nificant changes to special-
ized gut epithelial cells, called 
Paneth cells. These cells 
contain granules packed with 
antimicrobial peptides (Figure 
1, top). Disrupting the mouse 
Atg16L1 ortholog decreased 
how much antimicrobial pep-
tides their Paneth cells pro-
duced (Cadwell et al., 2010), 
and it increased the secretion 
of the proinflammatory cytok-
ines IL-1β and IL-18 by mac-
rophages (Saitoh et al., 2008). 
Now, in this issue of Cell, 
Cadwell et al. (2010) character-
ize environmental factors that 
interact with reduced func-
tionality of ATG16L1 to cause 
inflammation in the small 
intestines of mice. Common 
 diseases are the result of oblig-
atory interactions between 
many genetic susceptibility 
alleles and equally numerous, 
but largely unknown, environ-
mental factors (Todd, 2010). 
These new results by Cadwell 
et al. (2010) demonstrate how 
findings from GWAS may help 
to provide the first glimpses of 
the new frontier of gene-envi-
ronment interactions.
In a serendipitous obser-
vation, Cadwell et al. (2010) found that 
moving the Atg16L1-deficient mice from 
conventional barrier living conditions to 
an enhanced barrier facility (i.e., a “super 
pathogen-free” environment) surprisingly 
protected the mice from the Paneth cell 
phenotype of aberrant granule packag-
ing (Figure 1). It could have taken years 
to pinpoint the key difference between 
the two living conditions, yet the authors, 
with foresight and expertise in virology, 
did just this remarkably quickly. They 
found that the mice living a conventional 
lifestyle were infected with norovirus, 
which induced the Paneth cell abnor-
malities and gut inflammation when the 
Atg16L1 mutation was present. Further-
more, the effect was specific for a par-
ticular strain of norovirus (MNV CR6) 
and required persistent infection in the 
Atg16L1-deficient mice (Cadwell et al., 
2010).
In accord with Saitoh et 
al. (2008), Cadwell and col-
leagues (2010) also showed 
that exposure of the Atg16L1-
deficient mice to a toxin 
induces intestinal inflamma-
tion that resembles Crohn’s 
disease. Further, the severity 
of this environmental insult 
depends not only on disrup-
tion of the Atg16L1 gene and 
infection with norovirus but 
also on the presence of com-
mensal bacteria in the gut (i.e., 
the microbiome). Finally, they 
reported that the proinflam-
matory cytokines IFNγ and 
TNFα were required for the 
pathology. Thus, in a mouse 
model, the authors connect 
all of the factors one would 
expect to be involved in the 
origin of a common immune 
disease: a time-dependent 
and complex interaction 
among common gene poly-
morphisms, the immune sys-
tem, the microbiome, envi-
ronmental toxins, and the 
individual’s infection history 
(Cadwell et al., 2010).
A link between the activ-
ity of the gut microbiome and 
the development of a chronic 
disease is not without prec-
edent. Previous studies have 
implicated this highly diverse 
bacterial soup in obesity and 
type 1 diabetes (Wen et al., 
2008). In addition, some inves-
tigators have puzzled over the 
observation that the com-
mon genetic variants identi-
fied by GWAS explain little of 
the familial clustering of these 
diseases. Because babies 
inherit their microbiome from 
their mothers during birth, microbiome 
transmission could be a major factor in 
explaining the apparent strong herita-
bility of many common diseases (Todd, 
2010). Characterizing how the micro-
biome contributes to health and disease 
is well underway, particularly with the 
recent advent of high-throughput “next-
generation” DNA sequencing methods. 
Deep sequencing, which can detect 
sequences or mutations occurring at very 
figure 1. environmental and genetic factors Required for crohn’s-
like disease in mice
An allele of the human autophagy gene ATG16L1 predisposes individuals to 
an inflammatory bowel disorder, called Crohn’s disease. Patients homozygous 
for this disease allele display morphological abnormalities in the granules of 
their specialized gut epithelial cells, called Paneth cells (Cadwell et al., 2008).
(Top) Cadwell et al. (2010) now show that in a mouse model of Crohn’s dis-
ease in which the mouse Atg16L1 ortholog is disrupted, the Paneth cells have 
a normal phenotype when the mice are raised in virus-free enhanced barrier 
facilities.
(Bottom) However, in conventional living conditions these mutant mice are in-
fected with norovirus and develop similar abnormalities in the Paneth cells as 
those observed in patients with Crohn’s disease. This pathology also depends 
on the interactions of commensal bacteria, the gut innate immune system, 
and the production of proinflammatory cytokines.
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low frequencies, is also being applied to 
the human virome, but this work is in its 
infancy (Virgin et al., 2009).
To be clear, Cadwell and coworkers 
are not arguing that Crohn’s disease is 
caused by infection with norovirus or by 
any other single microbe. The environ-
mental factors that predispose to and 
protect from Crohn’s disease remain 
uncertain, but the balance among com-
mensal and pathogenic gut bacteria and 
viral infections is likely to be part of the 
story. Cadwell et al. (2010) also do not 
reveal which cells in the mouse gut or its 
immune system are infected with murine 
norovirus. An intracellular receptor, 
interferon-induced helicase C domain 1 
(IFIH1) or MDA5, is required to suppress 
murine norovirus infection (Virgin et al., 
2009). However, although this receptor 
is widely expressed, the murine norovi-
rus preferentially infects dendritic cells 
and macrophages of the immune system 
(McCartney et al., 2008).
Interestingly, mutant alleles of the 
IFIH1 gene encoding this virus recep-
tor are associated with protection from 
autoimmune diseases such as type 1 
diabetes and systemic lupus erythema-
tosus (Todd, 2010) (http://www.t1dbase.
org/page/Regions/). Many studies have 
reported or proposed that infection with 
certain viruses and an increase in pro-
duction of the inflammatory molecule 
type 1 interferon are causes of these dis-
orders (Todd, 2010). Moreover, the Toll-
like receptors TLR7 and TLR8 expressed 
in the gut are also sensors of viral infec-
tions, and variations in their genes have 
been associated with type 1 diabetes 
and celiac disease (an inflammatory dis-
order of the small intestine) (Todd, 2010). 
In addition, Saitoh et al. (2008) reported 
that TLR7 is involved in the Atg16L1-
mediated production of IL-1β. Combined 
with the IFIH1 findings, the new study by 
Cadwell and coworkers (2010) suggests 
that a variety of viruses may be cofactors 
in the development of immune diseases 
(Todd, 2010).
Despite the current revolution in 
human genetics and genomics, identifi-
cation of genes that control susceptibil-
ity and resistance to infectious diseases 
still lags behind the explosion of informa-
tion about gene variations implicated in 
chronic diseases. Researchers are still 
identifying the molecules that govern 
the persistence of viral infections, such 
as interleukin-10 and cytotoxic T-lym-
phocyte antigen 4 (CTLA-4) (Virgin et al., 
2009). Variants of the genes encoding 
these molecules occupy central posi-
tions in the newly discovered genetic 
architecture of chronic immune diseases 
(Todd, 2010). Together with the new 
work of Cadwell et al. (2010), these stud-
ies make an urgent and compelling case 
for characterizing the human virome and 
defining its effects on physiology and 
gene expression. In addition, we need 
to understand how the virome interacts 
with polymorphisms in the host genome 
and how numerous toxins in the environ-
ment alter this complex interplay (Patel 
et al., 2010).
GWAS and genome-wide expression 
studies, coupled to gene-to-phenotype 
approaches and mouse disease models, 
not only will facilitate the identification of 
key environmental factors contributing to 
common disorders, but they also under-
pin the hope for more etiology-based 
development of new therapeutics. For 
example, data from the Crohn’s disease 
GWAS are already yielding potential clin-
ical insights. The immunosuppressant 
rapamycin, which induces autophagy in 
cultured cells, improved symptoms in a 
patient with refractory Crohn’s disease 
(Massey et al., 2008).
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